---
figid: PMC11117599__antioxidants-13-00515-g004
figtitle: Anti-fibrosis mechanisms of H2 in fibrotic diseases
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11117599
filename: antioxidants-13-00515-g004.jpg
figlink: /pmc/articles/PMC11117599/figure/F4
number: F4
caption: The anti-fibrosis mechanisms of H2 in fibrotic diseases. H2 can decelerate
  fibrotic process modulation by targeting key signaling cascades such as JAK/STAT
  pathways, TGF-β/Smads pathways, and PI3K/AKT/mTOR pathways, in addition to diminishing
  ROS production through the up-regulation of Nrf2. Additionally, molecular hydrogen
  is capable of inhibiting the assembly of the NLRP3 inflammasome and reducing the
  release of inflammatory mediators, thereby exerting control over the initiation
  and progression of fibrotic conditions
papertitle: Elucidating the Molecular Pathways and Therapeutic Interventions of Gaseous
  Mediators in the Context of Fibrosis
reftext: Aohan Li, et al. Antioxidants (Basel). 2024 May;13(5).
year: '2024'
doi: 10.3390/antiox13050515
journal_title: Antioxidants
journal_nlm_ta: Antioxidants (Basel)
publisher_name: MDPI
keywords: gaseous mediators | fibrosis | oxidative stress | inflammation | myofibroblasts
automl_pathway: 0.8504062
figid_alias: PMC11117599__F4
figtype: Figure
redirect_from: /figures/PMC11117599__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11117599__antioxidants-13-00515-g004.html
  '@type': Dataset
  description: The anti-fibrosis mechanisms of H2 in fibrotic diseases. H2 can decelerate
    fibrotic process modulation by targeting key signaling cascades such as JAK/STAT
    pathways, TGF-β/Smads pathways, and PI3K/AKT/mTOR pathways, in addition to diminishing
    ROS production through the up-regulation of Nrf2. Additionally, molecular hydrogen
    is capable of inhibiting the assembly of the NLRP3 inflammasome and reducing the
    release of inflammatory mediators, thereby exerting control over the initiation
    and progression of fibrotic conditions
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL4R
  - IL4
  - TGFB1
  - TGFB2
  - TGFB3
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SMAD3
  - SMAD2
  - NFE2L2
  - STAT6
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NLRP3
  - AKT1
  - AKT2
  - AKT3
  - SMAD4
  - MTOR
  - ACTA1
  - SOD1
  - SOD2
  - SOD3
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - CAT
  - CRAT
  - GLYAT
  - ROS
  - CAT
  - Fibronectin
---
